Skip to main content

Lichter Jay's Form 4 filing

Janux Therapeutics, Inc.JANX · filed Oct 18, 2024

Accession no.
0001415889-24-025436
Filed
Oct 18, 2024, 6:51 PM ET
Trade date
Oct 16-18, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 25 non-derivative transactions and 8 derivative transactions. Open-market sales total $77.5M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lichter JayCIK 000137635510% Owner
Avalon Ventures XI, L.P.CIK 000165290110% Owner
Avalon BioVentures SPV I, L.P.CIK 000184455010% Owner
Avalon BioVentures I, LPCIK 000187393510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 16, 2024Common StockSSaleDisposed−60,179$49.69F1−$2,990,294.512,761,291Direct
Oct 16, 2024Common StockSSaleDisposed−11,657$49.69F1−$579,236.33534,883Indirect
Oct 16, 2024Common StockSSaleDisposed−61,445$49.69F1−$3,053,202.052,819,366Indirect
Oct 16, 2024Common StockSSaleDisposed−29,474$50.61F5−$1,491,679.142,731,817Direct
Oct 16, 2024Common StockSSaleDisposed−5,710$50.61F5−$288,983.1529,173Indirect
Oct 16, 2024Common StockSSaleDisposed−30,094$50.61F5−$1,523,057.342,789,272Indirect
Oct 16, 2024Common StockMOption exerciseAcquired+4,968$17.00+$84,45611,855Direct
Oct 16, 2024Common StockMOption exerciseAcquired+2,070$10.73+$22,211.113,925Direct
Oct 16, 2024Common StockMOption exerciseAcquired+2,070$13.22+$27,365.415,995Direct
Oct 16, 2024Common StockMOption exerciseAcquired+1,407$39.80+$55,998.617,402Direct
Oct 16, 2024Common StockSSaleDisposed−10,957$50.80F7−$556,615.66,445Direct
Oct 17, 2024Common StockMOption exerciseAcquired+836$17.00+$14,2127,281Direct
Oct 17, 2024Common StockMOption exerciseAcquired+348$10.73+$3,734.047,629Direct
Oct 17, 2024Common StockMOption exerciseAcquired+348$13.22+$4,600.567,977Direct
Oct 17, 2024Common StockMOption exerciseAcquired+237$39.80+$9,432.68,214Direct
Oct 17, 2024Common StockSSaleDisposed−1,843$50.02F8−$92,186.866,371Direct
Oct 18, 2024Common StockSSaleDisposed−102,732$50.30F9−$5,167,419.62,629,085Direct
Oct 18, 2024Common StockSSaleDisposed−19,900$50.30F9−$1,000,970509,273Indirect
Oct 18, 2024Common StockSSaleDisposed−104,892$50.30F9−$5,276,067.62,684,380Indirect
Oct 18, 2024Common StockSSaleDisposed−15,462$51.18F10−$791,345.162,613,623Direct
Oct 18, 2024Common StockSSaleDisposed−2,995$51.18F10−$153,284.1506,278Indirect
Oct 18, 2024Common StockSSaleDisposed−15,788$51.18F10−$808,029.842,668,592Indirect
Oct 18, 2024Common StockSSaleDisposed−541,824$44.75−$24,246,6242,071,799Direct
Oct 18, 2024Common StockSSaleDisposed−104,957$44.75−$4,696,825.75401,321Indirect
Oct 18, 2024Common StockSSaleDisposed−553,219$44.75−$24,756,550.252,115,373Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 16, 2024Common StockMOption exerciseDisposed−4,968$0.00$022,776Direct
Oct 16, 2024Common StockMOption exerciseDisposed−2,070$0.00$09,490Direct
Oct 16, 2024Common StockMOption exerciseDisposed−2,070$0.00$09,490Direct
Oct 16, 2024Common StockMOption exerciseDisposed−1,407$0.00$06,309Direct
Oct 17, 2024Common StockMOption exerciseDisposed−836$0.00$021,940Direct
Oct 17, 2024Common StockMOption exerciseDisposed−348$0.00$09,142Direct
Oct 17, 2024Common StockMOption exerciseDisposed−348$0.00$09,142Direct
Oct 17, 2024Common StockMOption exerciseDisposed−237$0.00$06,072Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $49.50 to $50.45 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Referenced by the price of 3 transactions in Table I.

F5

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $50.46 to $51.25 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Referenced by the price of 3 transactions in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.76 to $51.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.97 to $50.18 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 3 transactions in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.97 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 3 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)